Evaluation of the volatile oil composition and antiproliferative activity of Laurus nobilis L. (Lauraceae) on breast cancer cell line models

Records of Natural Products

Volumn 8, Issue 2, 2014, Pages 136-147

  Abu Dahab, Rana ^a   Kasabri, Violet ^a   Afifi, Fatma Ulku ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Anticancer; Apoptosis; Jordan; Laurus nobilis; Volatile oils

Indexed keywords

ALCOHOL; ALPHA PHELLANDRENE; ANTINEOPLASTIC AGENT; AROMADENDRENE; BETA ELEMENE; BETA PINENE; CAMPHENE; CAMPHOR; CARYOPHYLLENE; CASPASE 8; CINEOLE; ESSENTIAL OIL; FAS LIGAND; HEXANOL; LAURUS NOBILIS EXTRACT; LIMONENE; LINALOOL; METHYLEUGENOL; OCIMENE; PINENE; PLANT EXTRACT; PROTEIN P21; PROTEIN P53; SABINENE; SULFORHODAMINE B; TERPENE DERIVATIVE; TERPINEN 4 OL; TERPINENE; TERPINOLENE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER THERAPY; CONTROLLED STUDY; ENZYME ASSAY; FRUIT; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LAURUS NOBILIS; MASS FRAGMENTOGRAPHY; NONHUMAN; PLANT LEAF; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84896481296     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. S.N. Garg, M.S. Siddiqui and S.K. Agarwal (1992). New fatty acid esters and hydroxyl ketones from fruits of Laurus nobilis, J. Nat. Prod. 55, 1315-9.
2. M. Sayyah, J. Valizadeh and M. Kamalinejad (2002). Anticonvulsant activity of the leaf essential oil of Laurus nobilis against pentylenetetrazole-and maximal electroshock-induced seizures, Phytomedicine. 9, 212-16.
3. E.Y. Qnais, F.A. Abdulla, E.G. Kaddumi and S.S. Abdullah (2012). Antidiarrheal activity of Laurus nobilis L. leaf extract in rats, J. Med. Food. 15, 51-7.
4. B. Kivcak and T. Mert (2002). Preliminary evaluation of cytotoxic properties of Laurus nobilis leaf extracts, Fitoterapia. 73, 242-3.
5. N. Kekre, C. Griffin, J. McNulty and S. Pandey (2005). Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother, Pharmacol. 56, 29-38.
6. K.H. Lee (1999). Anticancer drug design based on plant-derived natural products, J. Biomed. Sci. 6, 236-50.
7. H.N. Koo, S.H. Hong, B.K. Song, C.H. Kim, Y.H. Yoo and H.M. Kim (2004). Taraxacum officinale induces cytotoxicity through TNF-alpha and IL-1alpha secretion in Hep G2 cells, Life Sci. 74, 1149-57.
8. A.B. daRocha, R.M. Lopes and G. Schwartsmann (2001). Natural products in anticancer therapy. Curr. Opin, Pharmacol. 1, 364-9
9. T.J. Sayers (2011). Targeting the extrinsic apoptosis signaling pathway for cancer therapy, Cancer Immunol. Immunother. 60, 1173-80.
10. D. Berrington and N. Lall (2012). Anticancer activity of certain herbs and spices on the cervical epithelial carcinoma (HeLa) cell line. Evid Based Complement, Alternat. Med. 564927. Doi: 10.1155/2012/564927.
11. A.M. Saab, R. Tundis, M.R. Loizzo, I. Lampronti, M. Borgatti, R. Gambari, F. Menichini, F. Esseily and F. Menichini (2012). Antioxidant and antiproliferative activity of Laurus nobilis L. (Lauraceae) leaves and seed essential oils against K562 human chronic myelogenous leukemia cells, Nat. Prod. Res. 26, 1741-5.
12. E. Panza, M. Tersigni, M. Iorizzi, F. Zollo, S. De Marino, C. Festa, M. Napolitano, G. Castello, A. Ialenti and A. Ianaro (2011). Lauroside B, a megastigmane glycoside from Laurus nobilis (bay laurel) leaves, induces apoptosis in human melanoma cell lines by inhibiting NF-kB activation, J. Nat. Prod. 74, 228-33.
13. Y.L. Hsu, M.H. Yen, P.L. Kuo, C.Y. Cho, Y.T. Huang, C.J. Tseng, J.P. Lee and C.C. Lin (2006). San-Zhong-Kui-Jian-Tang, a traditional Chinese medicine prescription, inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis, Biol. Pharm. Bull. 29, 2388-94.
14. P.L. Kuo, Y.L. Hsu, S.C. Sung, W.C. Ni, T.C. Lin and C.C. Lin (2007). Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by pterocarnin A from the bark of Pterocarya stenoptera via the Fas-mediated pathway, Anticancer Drugs. 18, 555-62.
15. C.C. Wang, Y.M. Chiang, P.L. Kuo, J.K. Chang and Y.L. Hsu (2008). Norsolorinic Acid from Aspergillus nidulans Inhibits the Proliferation of Human Breast Adenocarcinoma MCF-7 Cells via Fas-Mediated Pathway, Basic. Clin. Pharmacol. Toxicol. 102, 491-7.
16. H. Wagner and S. Bladt (1996). Plant drug analysis, a thin layer chromatography atlas. Berlin, Springer-Verlag, 155, 176-178.
17. R.P. Adams (2007). In Identification of Essential Oil Components by Gas Chromatography / Mass Spectrometry. Allured Publ. Corp., IL, 4th edition.
18. J.Z. Al-Kalaldeh, R. Abu-Dahab and F.U. Afifi (2010). Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare and Salvia triloba against human breast adenocarcinoma cells, Nutr. Res. 30, 271-8.
19. F.U. Afifi and R. Abu-Dahab (2012). Phytochemical screening and biological activities of Eminium spiculatum (Blume) Kuntze (family Araceae), Nat. Prod. Res. 26, 878-882.
20. J.A. Aka and S.X. Lin (2012). Comparison of functional proteomics analyses of human breast cancer cell lines T47D and MCF7. PLoS One 7(2),e31532.
21. H.I. Al-Jaber, M.A. Al-Qudah, L.M. Barhoumi, I.F. Abaza and F.U. Afifi. (2012). Essential oil composition of the aerial parts of fresh and air-dried Salvia palaestina Benth. (Lamiaceae) growing wild in Jordan, Nat. Prod. Res. 26, 1179-87.
22. A. Kilic, H. Hafizoglu, H. Kollmannsberger and S. Nitz (2004). Volatile constituents and key odorants in leaves, buds, flowers and fruits of Laurus nobilis L, J. Agric. Food Chem. 52, 1601-1606.
23. M.K. Sangun, E. Aydin, M. Timur, H. Karadeniz, M. Caliskan and A. Ozkan. (2007). Comparison of composition of the essential oil of Laurus nobilis L. leaves and fruits from different regions of Hatay, Turkey, J. Environ. Biol. 28,731-3.
24. B. Ozcan, M. Esen, M.K. Sangun, A. Coleri and M. Caliskan (2010). Effective antibacterial and antioxidant properties of methanolic extract of Laurus nobilis seed oil, J. Environ. Biol. 31, 637-741.
25. M.R. Loizzo, R. Tundis, F. Menichini, M.A. Saab, G.A. Rtatti and F. Menichini (2007). Cytotoxic activity of essential oils from labiatae and lauraceae families against in vitro human tumor models, Anticancer Res. 27, 3293-3300.
26. C. Ramos, B. Teixeira, I. Batisa, O. Matos, N.R. Neng, J.M.F. Nogueira, M.L. Nunes and A. Marques (2012). Antioxidant and antibacterial activity of essential oil and extracts of bay laurel Laurus nobilis Linnaeus (Lauraceae) from Portugal, Nat. Prod. Res. 26, 518-529.
27. M. Suffness and J.M. Pezzuto (1990). Assays related to cancer drug discovery. In: Hostettmann, K. (Ed.), Methods in Plant Biochemistry: Assays for Bioactivity, vol. 6. Academic Press, London, pp. 71-133.
28. A. Barla, G. Topcu, S. Oksuz, G. Tumen and D.G.I. Kingston (2007). Identification of cytotoxic sesquiterpenes from Laurus nobilis L., Food Chem. 104, 1478-84.
29. M. Kaileh, W.V. Berghe, E. Boone, T. Essawi and G. Haegeman (2007). Screening of indigenous Palestinian medicianl plants for potential anti-inflammatory and cytotoxic activity. J. Ethnopharmacol. 113, 510-6.
30. S. Dall'Acqua, G. Viola, M. Giorgetti, M.C. Loi and G. Innocenti (2006). Two new sesquiterpene lactones from the leaves of Laurus nobilis, Chem. Pharm. Bull. 54, 1187-1189.
31. T.A. Lantto, M. Colucci, V. Zavadova, R. Hilyunen and A. Raasmaja (2009). Cytotoxicity of curcumin, resveratrol and plant extracts from basil, juniper, laurel and parsley in SH-Sy5Y and CV1-P cells. Food Chem. 117, 405-411.
32. S.H. Kwon, J.I. Nam, S.H. Kim, J.H. Yonn and K.S. Kim (2009). Kaempferol and quercetin, essential ingredients in Ginkgo biloba extract, inhibit interleukin-1beta-induced MUC5AC gene expression in human airway epithelial cells, Phytother. Res. 23, 1708-12
33. S. Attoub, A.H. Hassan, B. Vanhoecke, R. Iratni, T. Takahashi, A.M. Gaben, M. Bracke, S. Awad, A. John, H.A. Kamalboor, M.A. Al Sultan, K. Arafat, C. Gespach and G. Petroianu (2011). Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells, Eur. J. Pharmacol. 65, 18-25.
34. A.M Adio (2009). (-)-trans-β-Elemene and related compounds: occurrence, synthesis, and anticancer activity, Tetrahedron. 65, 5145-5149.
35. G. Santin, V.M. Piccolini, P. Veneroni, S. Barni, G. Bernocchi and M.G. Bottone (2011). Different patterns of apoptosis in response to cisplatin in B50 neuroblastoma rat cells, Histol. Histopathol. 26, 831-842.
36. M. Jiang, X. Yi, S. Hsu, C.Y. Wang and Z. Dong (2004). Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcription activity, Am. J. Physiol. Renal Physiol. 287, 1140-1147.